A detailed history of Arizona State Retirement System transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Arizona State Retirement System holds 28,833 shares of NBIX stock, worth $3.62 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,833
Previous 27,334 5.48%
Holding current value
$3.62 Million
Previous $3.76 Million 11.8%
% of portfolio
0.02%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$114.58 - $153.15 $171,755 - $229,571
1,499 Added 5.48%
28,833 $3.32 Million
Q2 2024

Aug 05, 2024

BUY
$130.86 - $143.19 $40,566 - $44,388
310 Added 1.15%
27,334 $3.76 Million
Q1 2024

May 07, 2024

BUY
$130.4 - $143.74 $24,124 - $26,591
185 Added 0.69%
27,024 $3.73 Million
Q4 2023

Jan 24, 2024

BUY
$106.07 - $132.76 $23,229 - $29,074
219 Added 0.82%
26,839 $3.54 Million
Q3 2023

Nov 06, 2023

BUY
$94.02 - $117.1 $376 - $468
4 Added 0.02%
26,620 $2.99 Million
Q2 2023

Aug 01, 2023

SELL
$89.53 - $104.87 $119,343 - $139,791
-1,333 Reduced 4.77%
26,616 $2.51 Million
Q1 2023

Apr 27, 2023

BUY
$94.11 - $123.02 $82,628 - $108,011
878 Added 3.24%
27,949 $2.83 Million
Q4 2022

Feb 07, 2023

BUY
$106.72 - $127.06 $88,470 - $105,332
829 Added 3.16%
27,071 $3.23 Million
Q3 2022

Nov 07, 2022

SELL
$92.03 - $107.81 $31,290 - $36,655
-340 Reduced 1.28%
26,242 $2.79 Million
Q2 2022

Jul 28, 2022

BUY
$75.79 - $100.07 $13,263 - $17,512
175 Added 0.66%
26,582 $2.59 Million
Q1 2022

May 04, 2022

BUY
$72.45 - $94.81 $46,150 - $60,393
637 Added 2.47%
26,407 $2.48 Million
Q4 2021

Feb 04, 2022

SELL
$79.65 - $106.22 $60,772 - $81,045
-763 Reduced 2.88%
25,770 $2.2 Million
Q3 2021

Nov 12, 2021

SELL
$86.18 - $99.03 $1,723 - $1,980
-20 Reduced 0.08%
26,533 $2.55 Million
Q2 2021

Aug 02, 2021

BUY
$89.43 - $102.27 $86,031 - $98,383
962 Added 3.76%
26,553 $2.58 Million
Q1 2021

May 06, 2021

BUY
$87.57 - $119.4 $16,375 - $22,327
187 Added 0.74%
25,591 $2.49 Million
Q4 2020

Jan 28, 2021

SELL
$86.91 - $108.33 $125,150 - $155,995
-1,440 Reduced 5.36%
25,404 $2.44 Million
Q3 2020

Nov 05, 2020

BUY
$96.16 - $135.15 $617,443 - $867,798
6,421 Added 31.44%
26,844 $2.58 Million
Q2 2020

Aug 04, 2020

BUY
$85.09 - $130.36 $24,591 - $37,674
289 Added 1.44%
20,423 $2.49 Million
Q1 2020

May 05, 2020

BUY
$75.11 - $113.76 $1.51 Million - $2.29 Million
20,134 New
20,134 $1.74 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.